{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EMM"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EMM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EMM\",,,,,undefined,":{"symbol":"EMM","market":"US","secType":"STK","nameCN":"GLOBAL X EMERGING MARKETS ETF","latestPrice":26.1819,"timestamp":1745956800000,"preClose":25.997,"halted":0,"volume":757,"delay":0,"floatShares":660587,"shares":660587,"eps":0,"marketStatus":"Not Yet Opened","change":0.1849,"latestTime":"04-29 16:00:00 EDT","open":26.2,"high":26.2027,"low":26.09,"amount":19818.128,"amplitude":0.004335,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746000000000},"marketStatusCode":0,"adr":0,"exchange":"AMEX","adjPreClose":25.997,"sharesOutstanding":660587,"nav":25.95,"aum":17143982.56,"bidAskSpread":0,"volumeRatio":0.7612629507219709},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EMM\",,,,,undefined,":{"symbol":"EMM","floatShares":660587,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7612629507219709,"shares":660587,"dividePrice":0.21291,"high":26.2027,"amplitude":0.004335,"preClose":25.997,"low":26.09,"week52Low":22.98,"pbRate":"--","week52High":29.94,"institutionHeld":0,"latestPrice":26.1819,"eps":0,"divideRate":0.008132,"volume":757,"delay":0,"ttmEps":0,"open":26.2,"prevYearClose":26.5454,"prevWeekClose":25.9501,"prevMonthClose":25.2881,"prevQuarterClose":25.2881,"fiveDayClose":25.3562,"twentyDayClose":25.2881,"sixtyDayClose":26.7885},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EMM\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EMM\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522837332","title":"New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings","url":"https://stock-news.laohu8.com/highlight/detail?id=2522837332","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522837332?lang=en_us&edition=fundamental","pubTime":"2025-03-26 07:02","pubTimestamp":1742943720,"startTime":"0","endTime":"0","summary":"SAVANNAH and ORCHARD Phase II trials show the addition of savolitinib or datopotamab deruxtecan-dlnk to TAGRISSO upon disease progression demonstrates strong clinical activity. WILMINGTON, Del., March 25, 2025----New study results presented at the European Lung Cancer Congress  2025, March 26 to 29, demonstrate the role of AstraZeneca’s TAGRISSO , as monotherapy and as the backbone for novel combinations, across stages and settings of epidermal growth factor receptor-mutated  non-small cell lung cancer . Highlights include:. LAURA Phase III trial of TAGRISSO in unresectable, Stage III EGFRm NSCLC after chemoradiotherapy  .SAVANNAH Phase II trial of TAGRISSO plus savolitinib in advanced EGFRm NSCLC with high levels of MET overexpression and/or amplification following disease progression on 1st-line TAGRISSO (#2O).FLAURA2 Phase III trial of TAGRISSO plus chemotherapy as 1st-line treatment for advanced EGFRm NSCLC .Professor Virginia Harrison, EGFR Positive UK, said: \"For people undergoin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/study-results-reinforce-tagrisso-osimertinib-230200995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1829250122.USD","BK4195","AZN","BK4563","LU2456880835.USD","LU0889565916.HKD","BK4503","BK4213","BK4144","BK4080","LU2462157665.USD","PFS","BK4568","CRT","LU2236285917.USD","OS","TEN","BK4166","BK4585","LU0109394709.USD","QD","BK4007","ORR","BK4588","BK4211","LU2417539215.USD","BK4124","EMM","BK4097","BK4231","LU0320765992.SGD","ADC"],"gpt_icon":1},{"id":"2473124806","title":"Sydney ESG consultant EMM courts private equity; Moelis on tools","url":"https://stock-news.laohu8.com/highlight/detail?id=2473124806","media":"The Australian Financial Review","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473124806?lang=en_us&edition=fundamental","pubTime":"2024-10-07 16:33","pubTimestamp":1728289980,"startTime":"0","endTime":"0","summary":"Environmental scientists are preparing to break bread with PE deal makers at Sydney-headquartered EMM Consulting, a professional services firm whose 300-strong team advises corporates and governments on environmental, social and governance matters.EMM Consulting kicked off in 2008 and now has more than 300 employees. Loading...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.afr.com/street-talk/sydney-esg-consultant-emm-courts-private-equity-moelis-on-tools-20241007-p5kgg5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"afr_stock","symbols":["LU1878469433.USD","MC","BK4127","ESG","EMM"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EMM\",params:#limit:5,,,undefined,":[{"date":"2024-12-30","symbol":"EMM","amount":0.130315,"announcedDate":"2024-12-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"GLOBAL X EMERGING MARKETS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-07","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2025-01-07"},{"date":"2024-06-27","symbol":"EMM","amount":0.08259,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-27","defaultRemindTime":1719495000000,"name":"GLOBAL X EMERGING MARKETS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-27","currency":"USD","dateTimestamp":1719460800000,"payDate":"2024-07-05"},{"date":"2023-12-28","symbol":"EMM","amount":0.173028,"announcedDate":"2023-12-27","type":"dividend","market":"US","newRecordDate":"2023-12-29","defaultRemindTime":1703773800000,"name":"GLOBAL X EMERGING MARKETS ETF","recordDate":"2024-01-08","payableDate":"2023-12-29","currency":"USD","dateTimestamp":1703739600000,"payDate":"2024-01-08"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EMM\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-28","recordDate":"2023-12-29","paymentDate":"2024-01-08","value":0.173028,"currency":"USD"},{"executeDate":"2024-06-27","recordDate":"2024-06-27","paymentDate":"2024-07-05","value":0.08259,"currency":"USD"},{"executeDate":"2024-12-30","recordDate":"2024-12-30","paymentDate":"2025-01-07","value":0.130315,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EMM\",market:\"US\",delay:false,,,undefined,":{}}}